Co-Authors
This is a "connection" page, showing publications co-authored by Fabrizio Cantini and Daniela Matarrese.
Connection Strength
0.499
-
Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study. J Infect. 2020 10; 81(4):647-679.
Score: 0.222
-
Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact. J Infect. 2020 08; 81(2):318-356.
Score: 0.220
-
JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality. Sci Adv. 2021 01; 7(1).
Score: 0.058